Find uplifting stories about heroes, innovations, and solutions
19 results for "liver disease"
For the first time, people with a severe form of fatty liver disease have real medication options that can actually reverse damage. Two new drug classes are giving hope to 15 million Americans who previously had no treatment beyond diet and exercise.
Scientists discovered that a common vitamin found in most pharmacies could become a powerful treatment for fatty liver disease, which affects nearly one in three people worldwide. The breakthrough targets a specific genetic factor that drives the condition.
Patients with a rare liver disease finally have relief from debilitating itching that robbed them of sleep and quality of life. The FDA just approved the first treatment specifically designed to ease this painful symptom that affected thousands.
Researchers at UConn have patented a breakthrough treatment that could reverse fatty liver disease, a condition affecting billions worldwide with almost no current cure options. The innovative approach targets the root cause of the disease rather than just managing symptoms.
Researchers at UConn have created a promising new therapy that could stop and even reverse fatty liver disease, a condition affecting billions globally with few current treatment options. The innovative approach targets a master regulator in the liver that controls over 1,000 genes crucial for metabolic function.
Scientists discovered that two non-intoxicating cannabis compounds dramatically reduced liver fat and improved metabolic health in new research. The breakthrough offers hope for treating a disease affecting one-third of adults worldwide.
Scientists in Jerusalem discovered two non-psychoactive cannabis compounds dramatically reduced liver fat in lab studies, offering hope for the one-third of adults worldwide living with the most common chronic liver disease. The breakthrough could lead to new treatments for a condition with few approved medications.
Scientists discovered a rare genetic mutation that directly causes fatty liver disease, potentially affecting millions worldwide. The breakthrough could lead to new targeted treatments for a condition that strikes one in three adults.
Researchers in Israel discovered that two non-psychoactive cannabis compounds could treat fatty liver disease, which affects one in three adults worldwide and currently has no approved medication. The breakthrough could lead to the first drug treatment for a condition impacting millions.
A 56-year-old man in China became the first living person surgically connected to a genetically modified pig liver, which kept him alive until a human organ became available. He's now recovering well after receiving a human liver transplant.
Johns Hopkins researchers created an AI blood test that detects liver disease years before symptoms appear, potentially helping 100 million Americans at risk. The test reads DNA fragment patterns instead of hunting for specific mutations.
Scientists at MIT have developed tiny injectable liver tissues that could save thousands of patients who can't get transplants. The "satellite livers" stayed healthy in mice for two months and performed essential liver functions.
A natural molecule made by healthy gut bacteria could protect children from liver disease linked to their mother's pregnancy diet. University of Oklahoma scientists found the compound dramatically reduced fatty liver risk in mice, opening new doors for early prevention.
Scientists at MIT built a tiny working liver model that could revolutionize how we find treatments for liver disease affecting over 100 million Americans. The breakthrough offers hope for discovering drugs that actually work for everyone.
Scientists at Carnegie Mellon University are developing breakthrough 3D-printed liver tissue that could help patients survive while waiting for transplants. The living patch could buy crucial time for diseased livers to heal themselves. #
A groundbreaking hepatitis D treatment just won approval in China, offering hope to 12 million people worldwide living with one of the most severe forms of viral hepatitis. The drug represents a rare full-journey innovation, from basic science discovery to market-ready medicine, all developed domestically.
A new treatment for one of the deadliest forms of viral hepatitis just got approved in China, offering hope to 12 million people worldwide who had almost no options. The drug, developed entirely in China from discovery to delivery, blocks both hepatitis B and D viruses from entering liver cells.
A groundbreaking combination therapy has left nearly 9 in 10 hepatitis D patients with no detectable virus after two years of treatment. The results could transform care for a disease that often leads to liver failure within five years.
A new stem cell research center at a public hospital in Hyderabad aims to make cutting-edge regenerative therapy affordable for everyday patients. The facility will manufacture clinical-grade stem cells for trials targeting liver failure and other life-threatening conditions.